[1]
A. J. Chatla, J. P. R. Yerrabelly, N. Dharavath, and P. Shyam, “Design, Synthesis and Anticancer Activity of Novel Substituted (E)-2-Morpholinoquinoline- 3-carbaldehyde-O-((-1-aryl-1H-1,2,3-triazol-4-yl)methyl)oxime Derivatives”, ajc, vol. 36, no. 3, pp. 618–622, Feb. 2024.